FOXNEWS Special Report With Bret Baier February 11, 2022 23:33:00
Needed. the surge in omicron cases also brought on a flood of new data that led them to their decision today. >> makes sense for us to wait until we have the data from evaluation of a third dose before taking action. >> pfizer and its research partner bion tech issued this statement given that the study is advancing at rapid pace, the companies will wait for the three dose data as pfizer and bion tech continue to believe it may provide a higher level of protection in this age group. the companies expect to have the data in early april. the hold up is over questions about effectiveness rather t...